NCT05887882 2026-03-16
PNOC028
University of California, San Francisco
Phase 1 Recruiting
Clinical Trials
3 trialsNCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT07330050 2026-01-09
WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting